SPONSOR
Ottawa Heart Institute Research Corporation
Total Trials
10
Recruiting
10
Phases
Phase 4, Phase 2, Phase 3, Phase 3
Conditions studied: Mitral RegurgitationMitral Valve DiseaseHeart FailureCongenital Heart Disease (CHD)StrokeAtrial FibrillationTobaccoAscending Aortic Aneurysm EnlargementAscending Aorta AneurysmDiabetes Type 2
Ottawa Heart Institute Research Corporation is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Mitral Regurgitation, Mitral Valve Disease, Heart Failure, Congenital Heart Disease (CHD).
The trial portfolio spans Phase 4, Phase 2, Phase 3, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Ottawa Heart Institute Research Corporation
How many clinical trials has Ottawa Heart Institute Research Corporation sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by Ottawa Heart Institute Research Corporation, of which 10 are actively recruiting participants. These trials cover conditions including Mitral Regurgitation, Mitral Valve Disease, Heart Failure. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ottawa Heart Institute Research Corporation research focus on?
Ottawa Heart Institute Research Corporation clinical trials span Mitral Regurgitation, Mitral Valve Disease, Heart Failure, Congenital Heart Disease (CHD), Stroke, and additional conditions. The research pipeline includes Phase 4, Phase 2, Phase 3, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Ottawa Heart Institute Research Corporation clinical trial?
To participate in a Ottawa Heart Institute Research Corporation trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ottawa Heart Institute Research Corporation trials with current recruitment status updated daily.
Clinical Trials by Ottawa Heart Institute Research Corporation
NCT06547788
Recruiting
LEFT ATRIAL MONITORING IN PATIENTS BEFORE AND AFTER MITRAL SURGERY - LAMBDA STUDY
Mitral Regurgitation
NCT07585175
Recruiting
Transition and Transfer of Congenital Heart Disease Care From Pediatrics to Adulthood
Congenital Heart Disease (CHD)
NCT06670781
Recruiting
Standardized Goal-Directed vs. Self-Directed Valsalva Maneuver for the Assessment of Patent Foramen Ovale
Stroke
NCT02808260
Recruiting
Predicting Development of SCAF in Device Patients
Atrial Fibrillation
NCT06832085 Phase 4
Recruiting
Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation
Tobacco
NCT03536312
Recruiting
Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance
Ascending Aortic Aneurysm Enlargement
NCT05427084 Phase 2, Phase 3
Recruiting
Canagliflozin Targeting Vascular Inflammation
Diabetes Type 2
NCT03885635
Recruiting
Hemiarch vs Extended Arch in Type 1 Aortic Dissection
Aortic Dissection
NCT03103932
Recruiting
Biomarker Guided Discharge of Heart Failure Patients
Heart Failure; With Decompensation
NCT05047198 Phase 3
Recruiting
Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial
Ventricular Tachycardia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology